Status:
ACTIVE_NOT_RECRUITING
Scalable Communication Modalities for Returning Genetic Research Results
Lead Sponsor:
Boston University
Collaborating Sponsors:
University of Washington
MGH Institute of Health Professions
Conditions:
Hereditary Breast and Ovarian Cancer
Lynch Syndrome
Eligibility:
FEMALE
40+ years
Phase:
NA
Brief Summary
Efforts to examine the utility of alternate modalities for genetic results disclosure has widespread implications for how precision medicine research might yield direct health benefits for study parti...
Detailed Description
This study is a randomized controlled trial (RCT) within the Black Women's Health Study (BWHS) to test alternate communication modalities for results disclosure. The BWHS is an ongoing prospective coh...
Eligibility Criteria
Inclusion
- Women in the BWHS previously included in the targeted breast cancer sequencing project
Exclusion
- Women with known cognitive impairments
- Women with variant of uncertain significance (VUS) results from the sequencing study
Key Trial Info
Start Date :
March 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
932 Patients enrolled
Trial Details
Trial ID
NCT04407611
Start Date
March 6 2023
End Date
December 1 2025
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BU School of Public Health, the research is being conducted remotely
Boston, Massachusetts, United States, 02118